Evidence map›Paper›PMID 37065914›Full record

ArticleFrontiers in neuroscience2023

Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics.

Cécile Louveau, Mimi-Caterina Turtulici, Angèle Consoli, Christine Poitou, Muriel Coupaye, Marie-Odile Krebs, Boris Chaumette, Anton Iftimovici

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Cécile LouveauCentre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Mimi-Caterina TurtuliciCentre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Angèle ConsoliDepartment of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France.
Christine PoitouNutrition Department, Rare Diseases Center of Reference "Prader-Willi Syndrome and Obesity With Eating Disorders" (PRADORT), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, INSERM, Nutriomics, Sorbonne Université, Paris, France.
Muriel CoupayeNutrition Department, Rare Diseases Center of Reference "Prader-Willi Syndrome and Obesity With Eating Disorders" (PRADORT), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, INSERM, Nutriomics, Sorbonne Université, Paris, France.
Marie-Odile KrebsCentre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Boris ChaumetteCentre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France.
Anton IftimoviciCentre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fnins.2023.1126970.].

Indexed as

deletiondisomygeneticspersonalized medicinePrader–Willitopiramatetreatment

Identifiers

PMID37065914
PMCPMC10103458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.